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Abstract
Background: HIV-1 infection of the thymus contributes to the defective regeneration and loss of CD4
+ T cells in
HIV-1-infected individuals. As thymic dendritic cells (DC) are permissive to infection by HIV-1, we examined the
ability of thymic DC to enhance infection of thymocytes which may contribute to the overall depletion of CD4
+ T
cells. We compared productive infection in isolated human thymic and blood CD11c
+ myeloid DC (mDC) and
CD123
+ plasmacytoid DC (pDC) using enhanced green fluorescent protein (EGFP) CCR5 (R5)-tropic NL(AD8) and
CXCR4 (X4)-tropic NL4-3 HIV-1 reporter viruses. Transfer of productive HIV-1 infection from thymic mDC and pDC
was determined by culturing these DC subsets either alone or with sorted thymocytes.
Results: Productive infection was observed in both thymic pDC and mDC following exposure to R5 HIV-1 and X4
HIV-1. Thymic pDC were more frequently productively infected by both R5 and X4 HIV-1 than thymic mDC (p =
0.03; n = 6). Thymic pDC efficiently transferred productive R5 HIV-1 infection to both CD3
hi (p = 0.01; mean fold
increase of 6.5; n = 6) and CD3
lo thymocytes (mean fold increase of 1.6; n = 2). In comparison, transfer of
productive infection by thymic mDC was not observed for either X4 or R5 HIV-1.
Conclusions: The capacity of thymic pDC to efficiently transfer R5 HIV-1 to both mature and immature thymocytes
that are otherwise refractory to R5 virus may represent a pathway to early infection and impaired production of
thymocytes and CD4
+ T cells in HIV-1-infected individuals.
Background
The thymus is critical to CD4
+ T cell homeostasis and is
the major source of naïve CD4
+ T cells throughout life
[1-4]. HIV-1 can inhibit proliferation of immature thy-
mocytes [5] and/or can directly infect CD4
+ thymocytes
[6] leading to impaired production of CD4
+ T cells,
which contributes to progressive CD4
+ T cell decline.
Studies in both humanised mouse models [7-10] and
human fetal thymic organ cultures [9] have shown thy-
mocytes to be infected with both CCR5 (R5) and
CXCR4 (X4)-tropic HIV-1. In comparison, single cell
suspensions of thymocytes are relatively resistant to
infection with R5 HIV-1 [11]. As CXCR4 is highly
expressed on most thymocytes, while CCR5 is only
expressed on a relatively small proportion of thymocytes
[12], the mechanism by which thymocytes are infected
with R5 virus remains unclear.
Dendritic cells (DC) in the thymus cluster closely with
resident thymocytes and are permissive to HIV-1 infec-
tion [13,14]. Thymic DC can be broadly grouped into a
major CD123
+ plasmacytoid (pDC) population and a
smaller CD11c
+ myeloid (mDC) population [15-17].
While the function of thymic pDC remains unknown, it
has been suggested that they play a role in protecting
the thymus against viral infection [15,18] and/or influ-
ence positive selection of thymocytes [19,20] through
the secretion of IFN-alpha. Following HIV-1 infection in
vitro, IFN-alpha is produced by thymic pDC but does
not inhibit viral replication within thymocytes [18]. Thy-
mic pDC may instead play the role of a ‘Trojan horse’
[14]. We hypothesised that HIV-1-infected thymic DC
facilitate infection of thymocytes with R5 virus following
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pDC and mDC facilitate infection of CD4
+ T cells iso-
l a t e df r o mb l o o d[ 2 1 ] .H e r ew es h o wt h a tt h y m i cp D C
are permissive to high levels of both productive R5 and
X4 HIV-1 infection. Furthermore, we demonstrate
transfer of productive R5 HIV-1 infection from thymic
pDC to CD3
hi and CD3
lo thymocytes. These results
demonstrate the importance of thymic pDC in facilitat-
ing infection of immature and mature thymocytes.
Results
Three subpopulations of DC exist in the human thymus
We first characterised the frequency and phenotype of
DC in human thymus and then quantified expression on
these DC subsets of the HIV-1 co-receptors CXCR4 and
CCR5, as well as C-type lectins known to be important
for HIV-1 transfer. We used methods of isolation simi-
lar to previous studies of thymic DC [15-17] and identi-
fied three predominant thymic DC subpopulations in
the human thymus, based on the expression of the
known DC surface markers CD11c, CD123 and HLA-
DR (Figure 1A and 1B). These populations were HLA-
DR
intCD123
+CD11c
-,H L A - D R
int/hiCD123
-CD11c
lo,a n d
HLA-DR
int/hiCD123
-CD11c
hi (Figure 2A and 2B). CD14
expression was determined to eliminate the possibility
of monocyte contamination; all DC subsets were nega-
tive for CD14. The HLA-DR
intCD123
+CD11c
- pDC
represented the predominant population of DC in the
thymus (77% of total DC). This was in contrast to
human blood, where mDC were the major subset of DC
(68% of total DC; data not shown). Like blood pDC, thy-
mic pDC expressed high levels of the cytokine receptor
CD123, while they lacked both expression of the mye-
loid marker CD1c and the adhesion and co-stimulatory
molecules CD11b and CD11c. A smaller population of
myeloid-related CD123
-CD11c
lo DC was also identified
(20% of total DC). These cells were heterogeneous for
HLA-DR expression, with 72% of cells expressing high
levels of HLA-DR, while the remaining cells expressed
intermediate levels (Figure 2B).
A third minor subpopulation of CD123
-CD11c
hi DC
was also observed (3% of total DC), with the majority of
cells (66% of CD11c
hi) expressing high levels of HLA-
DR and CD86. Additionally, 67% of CD11c
hi DC
expressed CD11b and 88% of the CD11c
hi DC expressed
the P-selectin glycoprotein ligand 1 M-DC8, a marker
shared with the CD16
+ DC subset found in blood [22].
The M-DC8
+ thymic DC did not express CD16 (not
shown). These data demonstrated that the major DC
population in the thymus is pDC, followed by mDC and
Figure 1 Strategy for the isolation and sorting of thymic pDC and mDC. (A) Thymus tissue was digested to create a single cell suspension.
Using Nycodenz density centrifugation cells were then divided into a low-density (LDF) and a high-density fraction (HDF). Thymocyte
subpopulations were sorted from the HDF. DC were enriched from the LDF by magnetic bead depletion (MACS) and high speed flow
cytometric cell sorting (FACSAria). (B) Gating strategy for sorting thymic DC; (i) Viable cells were selected by live gating using forward (FSC) and
side scatter (SSC); (ii and iii) Doublets were excluded based on FSC-width (W), -height (H) and SSC-W, H; (iv) HLA-DR-positive, cocktail (CD3,
CD15, CD19, GlyA)-negative cells were selected and (v) CD123
+ (pDC) and CD11c
+ (mDC) populations were sorted. On average, the recovery of
isolated DC was 3 × 10
5 pDC and 2 × 10
5 mDC per 10
9 total thymic cells. The purity for pDC and mDC was always greater than 98%.
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Page 2 of 12Figure 2 Phenotypic identification of thymic DC. (A) DC were gated based on CD123, CD11c
lo or CD11c
hi expression. (B) A major
plasmacytoid (pDC; HLA-DR
intCD123
hiCD11c
-; 77.1%); a smaller myeloid (HLA-DR
int/hiCD123
-CD11c
lo; 20.4%); and a minor myeloid-related M-DC8
+
(HLA-DR
int/hiCD123
-CD11c
hiM-DC8
+; 2.5%) DC population were identified. Expression of myeloid antigens (CD1c and CD14), adhesion and co-
stimulatory molecules (CD11c and CD11b), HIV-1 receptors (CD4, CXCR4 and CCR5), maturation markers (CD83 and CD86), C-type lectin receptors
(DC-SIGN, DEC-205 and MR), CD123, HLA-DR and M-DC8 was determined. Mean fluorescence intensity (MFI) > 2000 (+++), MFI 500-2000 (++),
MFI 60-500 (+) or absent (-). * ≥ 50% of population positive (representative data from 2-3 separate experiments).
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hi DC that
also express M-DC8.
We next determined the expression of surface recep-
tors required for HIV-1 entry on each thymic DC sub-
set. CD4, CCR5 and CXCR4 were detected in all three
thymic DC subsets. In contrast, the C-type lectin recep-
tors DC-SIGN, DEC-205 and MR, which have been
shown to play a role in the transfer of HIV-1, were only
detected on a small proportion of mDC/CD11c
hi DC
(Figure 2B).
Thymic DC show a differential susceptibility to productive
HIV-1 infection
We then infected freshly isolated CD123
+ pDC and
CD11c
+ mDC (comprising both the M-DC8
+ and M-
DC8
- DC subsets) from unmatched human blood and
thymus (n = 12). The DC populations were mock
infected with media alone or infected with either X4 or
R5 viruses containing a deletion in the nef gene (-nef)
and replaced with enhanced green fluorescent protein
(EGFP) [pDRNL4-3-nef/EGFP or pDRNL(AD8)-nef/
EGFP respectively] (Figure 3A). Both thymic DC subsets
were productively infected by HIV-1; however, the fre-
quency of both R5 and X4 HIV-1-infected cells was sig-
nificantly greater in thymic pDC compared to donor-
matched thymic mDC (p = 0.03; n = 6; Figure 3A). Fol-
lowing infection with R5 HIV-1, the median number of
EGFP
+ cells was higher in thymic pDC (233 events/10
4
viable cells; n = 6) than in thymic mDC (6 events/10
4
viable cells; p = 0.03). Thymic pDC were infected with
X4 HIV-1 (207 events/10
4 viable cells) at a similar fre-
quency to R5 HIV-1. In contrast, thymic mDC were
more frequently infected with X4 (78 events/10
4 viable
cells) than R5 HIV-1 (6 events/10
4 viable cells; p =
0.004). Furthermore, no EGFP
+ cells were present fol-
lowing infection of either pDC or mDC in the presence
of azidothymidine (AZT), indicating that EGFP expres-
sion represented the production of new virus proteins
within the DC during a spreading infection (Figure 3B).
In comparison to thymic DC cultures, we did not
detect a statistically significant difference in EGFP
+ cells
in blood pDC compared to blood mDC following infec-
tion with both R5 (10 and 1 events/10
4 viable cells
respectively; p = 0.22) and X4 HIV-1 (22 and 59 events/
Figure 3 Frequency of R5 and X4 HIV-1 infection in blood and thymic DC. (A) Plasmacytoid DC (pDC) and myeloid DC (mDC) were isolated
from blood and thymus tissue. Cells were exposed to either R5 (NL(AD8)-nef/EGFP) or X4 HIV-1 (NL4-3-nef/EGFP). The number of EGFP
+ cells was
determined by flow cytometry 5 days post-infection. Each symbol represents the mean of duplicate experiments from a single donor. The edges
of the boxes represent the 25 and 75 percentiles, the horizontal line in the box is the median and the whiskers extend to the minimum and
maximum data points. * indicates a p value of < 0.05 as determined by the Wilcoxon signed rank test. (B) In some experiments the DC were
pre-treated with AZT (0.1 μM) prior to infection. Representative results form 4 experiments are shown. (C) DC viability was assessed by flow
cytometry following 5 days of culture and expressed as a proportion of live cells over total cells. Each column represents the mean of 5-6
experiments ± SEM.
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4 viable cells respectively; p = 0.44). Blood pDC were
equally infected by X4 and R5 HIV-1 (p = 0.38). In con-
trast, blood mDC, like thymic mDC, were more permis-
sive to X4 than R5 virus (p = 0.01). Finally, when we
compared thymic and blood DC, we found that thymic
mDC were significantly more permissive to productive
infection by X4 HIV-1 compared with mDC purified
from blood (p = 0.004). While thymic pDC were signifi-
cantly more permissive to R5 HIV-1 than blood pDC (p
= 0.01).
Although DC were cultured with both IL-3 and GM-
CSF, at concentrations that maintain cell viability and
allow for some maturation of DC [23,24], thymic and
blood mDC had a lower viability than thymic and blood
pDC (as determined by flow cytometry live gating analy-
sis using forward and side scatter parameters) following
5 days of cell culture and infection with either R5 or X4
virus, (p = 0.06; Figure 3C). However, when the number
of total EGFP
+ cells was analysed rather than the num-
ber of viable EGFP
+ cells, our observations remained
unchanged, suggesting that the low viability of mDC did
not contribute to their differential susceptibility to infec-
tion when compared to pDC.
Thymic pDC transfer R5 but not X4 HIV-1 to mature
single-positive thymocytes
We next determined whether HIV-1 infection of thymic
DC facilitated infection of thymocytes. Human blood
and thymic DC were infected with R5 or X4 HIV-1 for
2 h and then washed to remove any unbound virus. The
HIV-1-exposed blood and thymic DC were then cul-
tured for 24 h before adding an equal number of unin-
fected autologous peripheral blood mononuclear cells
(PBMC) or CD3
hi thymocytes respectively. Culture was
continued for 4 days before analysis by flow cytometry
(Figure 4A). We assumed that any increase in the pro-
portion of EGFP
+ cells following infection of the co-cul-
tures, compared to infection of DC cultured alone,
would indicate viral transfer from the DC to either the
PBMC or CD3
hi thymocytes (Figure 4B). If transfer of
virus did not occur, then the proportion of EGFP
+ cells
would be expected to decrease due to the dilution of
DC with PBMC or thymocytes.
As previously reported [11], thymocytes in single cell
suspension were productively infected by X4 but not R5
HIV-1 infection (Figure 4C). Following exposure to X4
HIV-1, the highest median level of EGFP
+ cells was
detected in the mature CD3
hi thymocytes (923 events/
10
4 viable cells), with fewer EGFP
+ cells observed in the
less mature CD3
lo and CD3
- thymocytes (217 and 156
events/10
4 viable cells respectively; p = 0.03). In com-
parison, following exposure to R5 HIV-1 we only
detected a very low number of EGFP
+ cells in the
mature CD3
hi thymocytes (2 events/10
4 viable cells) and
no infection in the CD3
lo or CD3
- thymocytes. This
data confirmed previous findings of relative resistance of
thymocytes to R5 infection in vitro.
In this culture system, only R5 exposed thymic pDC
were able to transfer productive infection to CD3
hi thy-
mocytes. The number of EGFP
+ cells observed in the
thymic pDC-thymocyte co-cultures was significantly
higher when compared to the pDC cultured alone
(mean fold increase of 6.5; p = 0.01; Figure 4B and 4C).
Transfer was confirmed in the pDC-CD3
hi thymocyte
co-cultures by demonstrating that the majority of EGFP
+ cells were also positive for CD3 expression (mean of
7 0 % ;n=2 ;F i g u r e4 D ) .I nt w oe x p e r i m e n t s ,C D 3
lo thy-
mocytes were added to the pDC 24 h post infection,
and transfer of R5 virus to the CD3
lo thymocytes was
also observed, although transfer was less efficient (mean
fold increase of 1.65) than that observed to the CD3
hi
thymocytes. Thymic pDC did not, however, transfer
productive X4 HIV-1 infection to CD3
hi thymocytes as
the proportion of EGFP+ cells observed in the thymic
pDC-thymocyte co-cultures was lower when compared
to the pDC cultured alone (125 and 207 events/104
viable cells respectively; Figure 4C).
In comparison, thymic mDC did not transfer produc-
tive R5 or X4 HIV-1 to CD3
hi thymocytes. The number
of EGFP
+ cells was similar following R5 and X4 HIV-1
infection in the mDC cultured alone (6 and 78 events/
10
4 viable cells respectively) when compared to those
cultured with CD3
hi thymocytes (8 and 50 events/10
4
viable cells respectively; Figure 4C).
In order to determine differences in the capacity of
DC from thymus and other sites to transfer HIV-1, we
next examined whether human blood mDC and pDC
transferred HIV-1 to unstimulated PBMC. Blood mDC
were shown to efficiently transfer both R5 (mean fold
increase of 65.9; p = 0.02; Figure 4C) and X4 HIV-1
(mean fold increase of 15.1; p = 0.03; Figure 4C) to
PBMC while blood pDC only transferred R5 HIV-1
(mean fold increase of 4; p = 0.03; Figure 4C). Addition-
ally, blood mDC were significantly more efficient at
t r a n s f e r r i n gR 5H I V - 1t oP B M Cc o m p a r e dt ob l o o d
pDC (p = 0.03).
Taken together, these experiments demonstrated that
human thymic and blood DC differed in their suscept-
ibility to X4 and R5 HIV-1 and also had a different
capacity for transfer of HIV-1. Importantly, thymic pDC
were able to transfer R5 virus to both CD3
hi and CD3
lo
thymocytes, and may explain how thymocytes are
infected with R5 virus.
pDC are located within the cortex and medulla in
uninfected and HIV-1-infected thymus tissue
Given that thymocytes of different maturation are found
in the cortex and medulla, and our findings demonstrated
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Page 5 of 12Figure 4 DC Transfer of R5 and X4 HIV-1: Blood versus thymus. (A) Method used to detect transfer of HIV-1. DC were infected with R5 (NL
(AD8)-nef/EGFP) or X4 (NL4-3-nef/EGFP) HIV-1. Mock PBMC and thymocytes were cultured in parallel. DC were either cultured alone for the
duration of the culture period (5 days), or at 24 h post-infection mock PBMC were added to the blood DC and mock CD3
hi/CD3
lo thymocytes were
added to the thymic DC at a 1:1 ratio. (B) Results from a single experiment demonstrate the gating strategy to determine the number of EGFP
+
cells following R5 infection of thymic pDC (left panels) and mDC (right panels) cultured alone or in the presence of CD3
hi thymocytes. In some
experiments, thymocytes were treated with 0.1 μM AZT prior to co-culture with DC. Representative plots from 4 donors are shown. (C) Blood (left
hand panels) and thymic (right hand panels) DC infected with either R5 (upper row) or X4 (lower row) HIV-1. Each symbol represents the mean of
duplicate experiments from a single donor. The edges of the boxes are the 25 and 75 percentiles, the horizontal line in the box is the median and
the whiskers extend to the minimum and maximum data points. * indicates a p value of < 0.05 as determined by the Wilcoxon signed rank test.
The results for 5-6 donors are shown. (D) Thymic pDC were infected with R5 HIV-1. At 24 h post-infection, uninfected CD3hi thymocytes were
added to the pDC at a 1:1 ratio. Culture was continued for 4 days, at which time the pDC-thymocyte co-cultures were labelled with CD3, and the
number of EGFP
+CD3
+ thymocytes was determined by flow cytometry. Columns represent the mean of 2 experiments ± SEM.
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1 infection to thymocytes, we next examined the distribu-
tion of pDC within the human thymus using antibodies to
CD123, HLA-DR, CD68, CD83 and CD40 (Figure 5A).
The medulla was identified by the presence of Hassall’s
corpuscles, increased HLA-DR expression, high CD40
expression and the presence of CD83
+ medullary DC. We
then identified cells that were CD123
+ and HLA-DR
+ (Fig-
ure 5A), indicative of pDC, in both the cortex and the
medulla of uninfected human thymus sections. To deter-
mine the effect of HIV-1 infection on pDC distribution in
the thymus, and because we were unable to access thymus
from HIV-1-infected patients, we examined the distribu-
tion of CD123
+ cells in thymus tissue collected from
severe combined immunodeficiency (SCID) mice trans-
planted with human fetal liver and thymic tissues (SCID-
hu-thy-liv) infected with R5 HIV-1BaL.A td a y7p o s ti n f e c -
tion, p24+ cells were visible in both the cortex and
medulla (Figure 5C), and CD123
+ cells were found to have
a similar distribution in thymus tissue from these infected
animals (Figure 5B) when compared to uninfected thymus
tissue (Figure 5A). These studies, therefore, confirmed that
pDC were present in both the cortex and medulla in
human thymus in the presence and absence of HIV-1
infection in vivo.
Discussion
The thymus plays a critical role in CD4
+ T cell homeos-
tasis. Thus, it is important to understand how thymo-
cytes and other thymic cells are infected with HIV-1.
Thymocytes express low levels of CCR5 and are permis-
sive to infection with R5 HIV-1 in vivo [8,25], but are
relatively resistant to R5 HIV-1 infection as single cell
suspensions. In this study we provide a mechanism for
how R5 HIV-1 infects thymocytes by demonstrating that
t h y m i cp D Cw e r ea b l et ot r a n s f e rp r o d u c t i v eR 5H I V - 1
infection to both CD3
hi and CD3
lo thymocytes. The effi-
cient transfer of R5 HIV-1 by thymic pDC to
Figure 5 Localisation of CD123
+ pDC in uninfected and HIV-1-
infected thymus tissue. Immunohistochemistry was performed on
fresh frozen thymus sections. Tissue sections were examined using
an Olympus BX50 microscope (Olympus, Centre Valley, PA) and
images captured using a ProSeries 3CCD camera (SciTech). Sections
were imaged with a 20x objective and montages were created and
composite images were colour deconvoluted using H-DAB filter in
ImageJ (National Institutes of Health, Bethesda, MD). The threshold
was set for 3,3’-Diaminobenzidine-positive cells (red). The medulla
(M) was identified by the presence of Hassall’s corpuscles (HC, open
arrow head), increased HLA-DR expression, high CD40 expression
and the presence of CD83
+ medullary DC. (A) In thymus tissue from
uninfected human donors the medulla and cortex [C] included cells
expressing high levels of CD123. (B) The distribution of CD123
+ cells
in thymic grafts from day 7 HIV-1BaL-infected SCID-hu-thy-liv mice
was similar to normal thymus tissue. (C) Sections were labelled with
isotype control or p24 antibody and processed for
immunohistochemistry using DAB. The cortical regions were imaged
at an original magnification of 20x and a montage created before
processing for colour deconvolution using ImageJ. The threshold
was set on the DAB channel, particles analysed using ImageJ, and
particle masks were then overlayed onto the original montaged
image. Scale bar is 200 μm.
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within the thymic cortex may provide a pathway for
R5 HIV-1 infection of both mature and immature
thymocytes.
Previous studies have demonstrated the ability of
blood and tissue DC to transfer HIV-1 infection to CD4
+ T cells [21,26-28]. In monocyte-derived DC (MDDC),
this transfer occurs in two phases. In the first phase,
transfer largely occurs via trans-infection, which is fol-
lowed by rapid decay of the virus. The second phase
includes transfer of virus from productively infected DC
to CD4
+ T cells [29]. Tissue DC isolated from tonsils
and skin (Langerhans cells) can transfer both R5 and X4
HIV-1 to CD4
+ T cells [13,30]; however, there have not
been any studies to determine whether thymic DC pos-
sess a similar ability. We found that thymic pDC effi-
ciently transferred productive R5 but not X4 HIV-1 to
mature CD3
hi thymocytes. While thymic pDC only
transferred R5 HIV-1, we observed high levels of both
R5 and X4 HIV-1 infection of thymic pDC. Therefore, it
is unlikely that the level of HIV-1 infection played a key
role in the ability of thymic pDC to transfer R5 HIV-1
infection. Thymic pDC had a similar expression of
CCR5 and CXCR4 and lacked the C-type lectin recep-
tors more commonly associated with DC transfer of
HIV-1. A potential explanation for the differences in
transfer of R5 and X4 HIV-1, by thymic pDC, may be
related to DC-thymocyte signalling. During clustering
with thymic pDC, the creati o no fa ni m m u n o l o g i c a l
synapse leads to partial activation of the thymocytes that
then allows for transfer of R5 but not X4 HIV-1. A
similar mechanism has previously been described in
MDDC [31,32].
Unlike HIV-1 infection of blood DC, we observed a
significantly higher number of EGFP
+ cells in thymic
pDC compared to thymic mDC following exposure to
both R5 and X4 HIV-1 (Figure 3A). This is similar to
the findings by Schmitt et al. who detected high levels
of p24 following both R5 and X4 HIV-1 infection of
thymic pDC, but failed to detect infection in the thymic
CD11c
+CD14
- mDC population [14]. These observations
were independent of the levels of CCR5 and CXCR4,
which were comparable across the two DC subsets [14].
Another study has shown that the fusion efficiency of
R5 viruses declines as DC mature and CCR5 expression
decreases, while X4 fusion efficiency does not change
with DC maturation [33]. While we did not observe
reduced CCR5 expression in thymic mDC, we demon-
strated that the majority (71%) of thymic CD11c
+ mDC
expressed high levels of HLA-DR and CD86 (Figure 2),
indicating a mature phenotype. This was in contrast to
the thymic pDC subset that expressed intermediate
levels of HLA-DR and lacked CD86. It is possible that
the less mature state of the thymic pDC may explain
the higher levels of productive R5 HIV-1 infection in
these cells compared to thymic mDC.
Thymic DC are a heterogenous population of cells,
with up to 5 populations previously described
[15-17,34]. Consistent with the findings of another
group [15], we identified a major HLA-DR
intCD11c
-
p D Cp o p u l a t i o n ,as m a l l e rH L A - D R
intCD11c
+ mDC
population and a minor CD11c
hi DC population within
the human thymus (Figure 2B). High expression of the
P-selectin glycoprotein ligand 1 (PSGL-1) M-DC8 on a
subpopulation (88%) of the CD11c
hi thymic DC is a
novel observation, however, th i sp o p u l a t i o ni su n l i k e l y
to significantly transfer HIV-1 to thymocytes as these
cells were included together with the thymic mDC, that
did not transfer virus. Instead, thymic M-DC8
+ DC may
contribute to the establishment of central tolerance, as
PSGL-1 has previously been shown to play a role in the
homing of antigen-bearing DC to the thymus [35].
Using immunohistochemistry we identified both
CD123
+ and HLA-DR
+ cells in the cortex and medulla
of uninfected thymus tissue (Figure 5A). These results
were consistent with those of previous studies that have
shown pDC in the cortex, in addition to the medulla
and cortico-medullary junction where the majority of
other DC subsets, including all the mature and mDC,
are localised [16,17,36]. Infection of the thymus with R5
HIV-1BaL did not affect the distribution of the CD123
+
or HLA-DR
+ cells (Figure 5B). X4 HIV-1 infection of
immature (CD3
-CD4
+/loCD8
-) thymocytes located in the
thymic cortex has been shown to prevent their matura-
tion into mature functional CD4
+ Tc e l l sin vitro
[37,38]. Given the high susceptibility of thymic pDC to
productive R5 HIV-1 infection, and their ability to
transfer this infection to both immature and mature thy-
mocytes, it is possible that the transfer of HIV-1 to
immature thymocytes located within the cortex could
prevent thymocyte maturation. Subsequently, a signifi-
cant decrease in all thymocyte subpopulations may
result, thus contributing to the overall depletion of CD4
+ T cells in HIV-1 infection [9].
Some limitations of the present study should be recog-
nised. EGFP reporter viruses are important tools for
evaluating productive HIV-1 infection in rare cells, such
as DC, because EGFP enables the identification of a sin-
gle infected cell. To construct the EGFP reporter
viruses, EGFP was inserted into the HIV-1 nef gene and
consequently, the nef gene was non-functional. Nef has
previously been shown to boost HIV-1 replication in
tonsil tissue [39]. Therefore, it is possible similar experi-
ments that utilise nef competent strains may result in
higher levels of productive infection of both thymic and
blood DC. Additionally, future studies would benefit
from the use of other R5 and X4 strains, including pri-
mary HIV-1 isolates, to confirm that our findings are
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isolates.
Limited production of CD4
+ T cells and delayed
recovery of thymus function following treatment of
HIV-1 infection are significant problems even with the
availability of highly active antiretroviral therapy. In this
s t u d yw ed e m o n s t r a t e dt h a tt h y m i cD Ca r eau n i q u e
population, differing from blood subsets, and that thy-
m i cp D Ca r eh i g h l yp e r m i s s i v et oH I V - 1i n f e c t i o na n d
efficiently transfer R5 HIV-1 to mature and immature
thymocytes. Understanding transfer of HIV-1 from thy-
mic DC to thymocytes may provide novel approaches to
improve thymic output in HIV-1 infected patients.
Conclusions
We have shown that the predominant thymic pDC sub-
population differs from thymic mDC in their greater
ability to support replication of both X4 (NL4-3) and R5
(NL(AD8))-tropic strains of HIV-1. In addition, NL
(AD8) replicated at higher levels in thymic pDC com-
pared with blood pDC. Thymic pDC but not mDC were
able to efficiently transfer NL(AD8) infection to both
CD3
hi and CD3
lo thymocytes. Thus pDC provide a pos-
sible pathway for R5 HIV-1 infection of thymocytes and
may contribute to the changes in thymic output seen in
HIV-1 infection.
Methods
Thymus
Normal human thymus samples were discarded tissue
from children (age range, 2 days to 7 years, n = 15)
undergoing corrective cardiovascular surgery (Royal
Children’s Hospital, Melbourne, Australia) and were
obtained with informed consent and under institutional
guidelines. All experiments, excluding the immunohisto-
chemistry, were conducted with this tissue. Infected thy-
mus tissue for immunohistochemistry was obtained
from HIV-1BaL-infected SCID-hu-thy-liv mice trans-
planted with human fetal liver and thymic tissue [40]
(kindly supplied by Ramesh Akkina, Colorado State Uni-
versity, Fort Collins, USA). Infection of the SCID-hu-
thy-liv thymus tissue was quantified in tissue digests by
real time PCR (iCycler; Biorad, Hercules, CA) using pre-
viously described methods to detect full length HIV-1
DNA with primers specific for LTR and Gag [41].
Thymocyte purification
Connective tissue was dissected from the human thymus
samples and the thymus tissue disrupted with a scalpel
blade prior to incubation with collagenase (1 mg mL
-1,
type II; Worthington Biochemical Corporation, Lake-
wood, NJ) and DNase (0.02 mg mL
-1,g r a d eI Ib o v i n e
pancreatic DNaseI; Worthington, Lakewood, NJ) in
RPMI-1640 media (Gilbco/Invitrogen, Grand Island,
NY) supplemented with 2% heat inactivated cosmic calf
serum (HyClone, Logan, UT). Incubation was continued
for 30 min at 37°C with intermittent agitation followed
by 5 min at room temperature with constant agitation.
To disrupt T cell-DC complexes, 100 mM EDTA was
added (10 mM final concentration) to the digest, and
incubation with agitation was continued for 5 min. The
suspension was then passed through a nylon mesh to
remove any remaining aggregates and/or stromal mate-
rial. The resulting single cell suspension was subjected
to Nycodenz (Axis-shield, Dundee, Scotland) density
gradient centrifugation as previously described [17], with
the exception that cells were resuspended in Nycodenz
at a density of 1.070 g/mL, rather than 1.068 g/mL, as
we found that this gave a greater DC yield. A low-den-
sity fraction (LDF) containing DC and a high-density
fraction (HDF) were recovered. Immature double-nega-
tive (CD3
-CD4
-CD8
-), double-positive (CD3
loCD4
+CD8
+) and mature single-positive (CD3
+CD4
+CD8
- or CD3
+CD4
-CD8
+) thymocytes were isolated from the HDF
using the monoclonal antibodies (mAbs); anti-HLA-DR-
allophycocyanin-cychrome-7 (APC-Cy-7), anti-CD3-phy-
coerythrin (PE; BD Biosciences, Bedford, MA) and FAC-
SAria cell sorting (BD Biosciences, Bedford, MA).
Phenotypic analysis of thymic DC subsets
Phenotypic analysis was performed on the enriched
thymic DC population recovered from the Nycodenz
LDF. Cells were immunostained with labelled mouse
mAbs and incubated for 25 min at 4°C. The mAbs
included anti-CD11c-APC, anti-CD123-PE, anti-HLA-
DR-PE/ Peridinin Chlorophyll Protein Complex
(perCP)/ APC-Cy7, anti-CD14-PE, anti-CD3-fluores-
cein isothiocyanate (FITC), anti-CD4 perCP, anti-
CCR5 FITC, anti-CXCR4 PE and APC (BD Bios-
ciences, San Jose, CA), anti-CD1c-FITC (Biosource
International, Camarillo, CA), anti-CD83 PE, anti-
CD86 APC, anti-DC-SIGN PE, anti-DEC-205 perCP-
Cy5, anti-MR APC (Biolegend, San Diego, CA), and
anti-M-DC8 (kindly supplied by Knut Schakel; Institute
of Immunology, Technical University of Dresden, Ger-
many). Cells labelled with anti-M-DC8 were washed
and incubated with goat anti-mouse IgM-biotin (Che-
micon, Boronia, Australia) for 20 min at 4°C and
finally washed and incubated with streptavidin-APC
(Becton Dickinson, Franklin Lakes, NJ, USA) for 25
min at 4°C.
Blood and thymic DC purification
For thymic DC purification, LDF cells were immunode-
pleted by magnetic cell sorting (Miltenyi Biotec, Ber-
gisch Gladbach, Germany) using a cocktail of mAbs;
anti-CD3 (OKT3), anti-CD15 (WEMG.I), anti-glyco-
phorin A (GlyA; 10FM.N) and anti-CD19 (FMC63; a
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Adelaide, Australia), and anti-mouse IgG-coated mag-
netic microbeads (Miltenyi Biotec). For blood DC purifi-
cation, PBMC isolated over Ficoll Hypaque gradients
(Pharmacia, Uppsala, Sweden) from fresh buffy coats
(Australian Red Cross Blood Service, Melbourne, Aus-
tralia) were immunodepleted using the mAbs; anti-CD3
(OKT3), anti-CD11b (OKM1), anti-CD19 (FMC63) and
anti-GlyA (10FM.N). The DC enriched populations were
immunostained with sheep anti-mouse-FITC (Chemi-
con, Boronia, Australia) to identify any remaining cock-
tail-positive cells. After blocking with 10% normal
mouse serum (Sigma, St. Louis, MO), cells were incu-
bated with the mAbs; anti-CD11c-APC, anti-CD123-PE
and anti-HLA-DR-APC-Cy7 (BD Biosciences). Using a
F A C S A r i a( B DB i o s c i e n c e s )w ew e r ea b l et os o r tt w o
DC subpopulations by gating on total HLA-DR
+ cells, in
order to exclude any contaminating basophils/mast
cells/natural killer cells, and then either CD11c
+ mDC
or CD123
+ pDC. The number of isolated DC did not
correlate with the thymus donor age and on average the
recovery was 3 × 10
5 pDCs and 2 × 10
5 mDCs per 10
9
total thymic cells. The purity of sorted cells was always
greater than 98% upon reanalysis (Figure 1).
Preparation and characterisation of HIV-1 stocks
HIV-1 viruses were generated by transfection of 293T
cells with either X4 or R5 viruses [pDRNL4-3-nef/
EGFP or pDRNL(AD8)-nef/EGFP respectively] (kindly
supplied by Damien Purcell, The University of Mel-
bourne, Melbourne, Australia). Supernatants were cen-
trifuged, filtered through 0.45 μm pore-size filters,
concentrated by ultra-centrifugation over a 20%
sucrose gradient and stored at -80°C. The 50% tissue
culture infective doses of the virus stocks was evalu-
ated by limiting dilution on PHA (10 μg/mL; Murex,
Kent, UK) stimulated PBMCs.
Infection with and transfer of HIV-1
PHA-stimulated PBMC (aPBMC; positive control for
productive infection), unstimulated PBMC, thymocytes
and DC subpopulations were either mock infected with
media alone or infected with viral supernatants at a
multiplicity of infection of 0.1 at 37°C in RC-10
(RPMI-1640 supplemented with 10% (vol/vol) cosmic
calf serum, 100 U/mL penicillin, 100 μg/mL strepto-
mycin, 2.9 mg/mL L-glutamine (Gilbco/Invitrogen,
Grand Island, NY)). Following 2 h of culture, the cells
were washed thoroughly to remove unbound virus.
Cells were cultured at 37°C in round-bottom 96-well
microtitre plates at a concentration of 10
5 cells/100 μL
RC-10. Thymocytes and PBMC were cultured with IL-
2 (10U/mL; Roche Diagnostics, Indianapolis, IN), while
DC were cultured with IL-3 (10 ng/mL; R&D Systems
Inc, Minneapolis, MN) and GM-CSF (40 ng/mL; R&D
Systems Inc), which have previously been reported to
increase DC survival [23]. In some experiments cells
were treated with the nucleoside reverse transcriptase
inhibitor azidothymidine (0.1 μM). In experiments
designed to detect transfer of HIV-1, blood or thymic
DC were pulsed with virus for 2 h as described above
and following 24 hours of culture, unstimulated mock
infected PBMC or CD3
hi/CD3
lo thymocytes were
added to blood or thymic DC respectively. Cells were
harvested 5 days post infection and the number of pro-
ductively infected (EGFP
+) cells detected using flow
cytometry. To confirm transfer, in some experiments
the pDC-CD3
hi thymocyte co-cultures were addition-
ally immunostained with anti-CD3-PE at day 5 post
infection.
Immunohistochemistry
Sections (5 μm) of cryopreserved OCT-embedded
thymus fragments were analysed by immunohisto-
chemistry. All incubations were performed at room
temperature in a humidified chamber. The sections
were exposed to 0.3% hydrogen peroxide solution to
neutralize endogenous peroxidases and then incubated
with blocking buffer (10% normal goats’ or fetal bovine
serum) for 15 min followed with IgG1 or the mAbs;
CD83, CD40 (diluted 1:200; AbD Serotec, Raleigh,
NC), CD123 (diluted 1:30; BD Biosciences), HLA-DR
(diluted 1:160), p24 (diluted 1:200) and CD68 (diluted
1:400; Dako, Glostrup, Denmark) for 1 h. After rinsing
in PBS, the sections were exposed to biotinylated-mAb
(Vectastain, Vector Laboratories Inc., Burlingame, CA)
for 30 min, rinsed with PBS and then incubated with
Steptavidin-HRP (Dako) for 30 min. Immunostaining
was revealed using 3,3’-Diaminobenzidine substrate
solution according to the manufacturer’sg u i d e l i n e s
(Dako). Sections were counterstained with haematoxy-
lin and blued with Scott’s tap water to enhance nuclear
definition. Finally, sections were dehydrated through 4
changes of alcohol (70%, 95% and 2 × 100%), cleared
in 3 changes of xylene and mounted with DePeX
(Merck, Darmstadt, Germany).
Flow cytometry
Flow cytometry was performed using a FACSCalibur
(Becton Dickinson) and results were analysed with Wea-
sel software (Walter and Elisa Hall Institute, Melbourne,
Australia).
Statistical analysis
Statistical analyses were performed with the Wilcoxon
paired sign rank sum test or Mann Whitney test using
GraphPad Prism (GraphPad software, La Jolla, CA). A p
value of less than 0.05 was considered significant.
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